RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Avenue Therapeutics - Stock

Avenue Therapeutics Net Income 2024

Avenue Therapeutics Net Income

-5.5 M USD

Ticker

ATXI

ISIN

US05360L2051

WKN

A2JH92

In 2024, Avenue Therapeutics's profit amounted to -5.5 M USD, a -46.96% increase from the -10.38 M USD profit recorded in the previous year.

The Avenue Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-

Avenue Therapeutics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Avenue Therapeutics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Avenue Therapeutics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Avenue Therapeutics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Avenue Therapeutics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Avenue Therapeutics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Avenue Therapeutics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Avenue Therapeutics’s growth potential.

Avenue Therapeutics Revenue, EBIT and net profit per share

DateAvenue Therapeutics RevenueAvenue Therapeutics EBITAvenue Therapeutics Net Income
2025e0 undefined-15.81 M undefined-3.19 M undefined
2024e0 undefined-13.58 M undefined-5.5 M undefined
20230 undefined-14.54 M undefined-10.38 M undefined
20220 undefined-8.04 M undefined-3.55 M undefined
20210 undefined-3.74 M undefined-3.73 M undefined
20200 undefined-5.21 M undefined-5.15 M undefined
20190 undefined-26.27 M undefined-25.91 M undefined
20180 undefined-21.82 M undefined-21.55 M undefined
20170 undefined-11.42 M undefined-12.26 M undefined
20160 undefined-2.38 M undefined-3.18 M undefined
20150 undefined-4.84 M undefined-5.23 M undefined

Avenue Therapeutics stock margins

The Avenue Therapeutics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Avenue Therapeutics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Avenue Therapeutics.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Avenue Therapeutics's sales revenue. A higher gross margin percentage indicates that the Avenue Therapeutics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Avenue Therapeutics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Avenue Therapeutics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Avenue Therapeutics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Avenue Therapeutics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Avenue Therapeutics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Avenue Therapeutics Margin History

Avenue Therapeutics Gross marginAvenue Therapeutics Profit marginAvenue Therapeutics EBIT marginAvenue Therapeutics Profit margin
2025e0 %0 %0 %
2024e0 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %

Avenue Therapeutics Aktienanalyse

What does Avenue Therapeutics do?

Avenue Therapeutics Inc is a biotechnology company specializing in the development of pain relief and anesthesia medications. The company was founded in 2015 and has since brought several products to the market. The core business of Avenue Therapeutics is the development of medications for pain and chronic pain. The company works with various compounds that selectively block pain receptors in the brain, including opioid receptors and cannabinoid receptors. The company currently has several products in the pipeline in different stages of clinical development. These include AV001, an anesthetic based on fentanyl used for pain relief in traumatic injuries and surgeries, and AV002, a pain medication based on tramadol used for acute and chronic pain. Another product being developed by the company is AV003, a synthetic cannabinoid compound that can be used for pain relief, as well as the treatment of anxiety disorders and seizures. In addition to their therapeutic effectiveness, all Avenue Therapeutics products are designed to be less addictive than traditional opioid medications. This goal is achieved through targeted dosing and special formulations. The business model of Avenue Therapeutics is based on the research, development, and marketing of pain medications and anesthetics. This includes production, clinical development, regulatory approval, and marketing in the healthcare market. Avenue Therapeutics has a wide range of customers, including hospitals, medical practices, and healthcare facilities, as well as patients suffering from pain and chronic pain. The products are offered in the North American market and can be purchased directly from the manufacturer or through sales by external distributors and retailers. An important goal of the company is to expand its product portfolio through the development of new and innovative pain medications. Therefore, the company continuously invests in research and development and collaboration with other companies and institutions to discover new technologies and compounds. However, the market for pain medications and anesthetics is highly competitive, and Avenue Therapeutics faces a range of challenges. These include stringent regulatory requirements, high costs for clinical trials, and a constant challenge to discover new technologies and compounds. Despite these challenges, Avenue Therapeutics has achieved impressive growth and a strong position in the market for pain medications and anesthetics in recent years. The company is in a good position to continue developing innovative medications in the future and provide its customers with a wide portfolio of high-quality pain relief drugs. Please indicate if these answers are enough or if you need further clarification. Avenue Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Avenue Therapeutics's Profit Margins

The profit margins of Avenue Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Avenue Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Avenue Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Avenue Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Avenue Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Avenue Therapeutics Stock

How much profit has Avenue Therapeutics made this year?

Avenue Therapeutics has made -5.5 M USD this year.

How has the profit developed compared to last year?

The profit has increased by -46.96% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Avenue Therapeutics publish its earnings?

Avenue Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Avenue Therapeutics?

The profits of Avenue Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Avenue Therapeutics?

You can learn more about the earnings of Avenue Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Avenue Therapeutics pay?

Over the past 12 months, Avenue Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avenue Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Avenue Therapeutics?

The current dividend yield of Avenue Therapeutics is .

When does Avenue Therapeutics pay dividends?

Avenue Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avenue Therapeutics?

Avenue Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Avenue Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avenue Therapeutics located?

Avenue Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avenue Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avenue Therapeutics from 6/30/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/30/2024.

When did Avenue Therapeutics pay the last dividend?

The last dividend was paid out on 6/30/2024.

What was the dividend of Avenue Therapeutics in the year 2023?

In the year 2023, Avenue Therapeutics distributed 0 USD as dividends.

In which currency does Avenue Therapeutics pay out the dividend?

The dividends of Avenue Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avenue Therapeutics

Our stock analysis for Avenue Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avenue Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.